Analysts love this biotech stock and give it major upside
The biotechnology sector has finally picked up steam after a tough 2022 — and for fund manager Hugh Dive, one stock stands out.
Virfor Pharma Precedence Research Australia Headquartered Atlas Funds Management Atlas Funds Like Dive Bayer Ag
Source: cnbc.com